eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Ipsen Ltd

190 Bath Road, Slough, Berkshire, SL1 3XE
Telephone: +44 (0)1753 627 777
Fax: +44 (0)1753 627 778
Medical Information Direct Line: +44 (0)1753 627 777
Medical Information e-mail: medical.information.uk@ipsen.com
Customer Care direct line: +44 (0)1753 627 627

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 23/09/2011
PIL Somatuline Autogel 60 mg, Somatuline Autogel 90 mg, Somatuline Autogel 120 mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/09/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 14/09/2011 and displayed until 23/09/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
Updated on 25/09/2009 and displayed until 14/09/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 03/06/2008 and displayed until 25/09/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 09/04/2008 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change to how to administer the medicine
Updated on 29/01/2002 and displayed until 09/04/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   lanreotide